Position in ABBV
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$17,303,269
+$2,974,811 QoQ
Shares Held
68,762
+4.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.84%
of 13F equity value
Holder Rank
#674
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mirador Capital Partners LP holds $28,463,151 across 9 Drug Manufacturers - General names. ABBV ranks #1 (60.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
68,762 | $17,303,269 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
48,795 | $2,811,567 | |
| 3 | LLY |
ELI LILLY & Co
|
1,657 | $1,987,455 | |
| 4 | JNJ |
Johnson & Johnson
|
7,410 | $1,881,917 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
14,099 | $1,781,267 | |
| 6 | PFE |
Pfizer Inc
|
45,835 | $1,103,706 | |
| 7 | MRK |
Merck & Co., Inc.
|
5,882 | $755,837 | |
| 8 | AMGN |
Amgen Inc
|
1,410 | $510,589 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,303,269 | 68,762 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $14,328,458 | 65,881 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $14,862,817 | 65,048 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $14,749,561 | 63,702 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $11,209,777 | 60,391 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $11,465,772 | 54,724 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $9,274,163 | 52,190 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $10,388,830 | 52,607 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $8,855,749 | 51,631 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $9,101,358 | 49,980 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $7,493,574 | 48,355 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $7,389,500 | 49,574 | Shares | Sole | 2023-10-05 | |
| 2023-06-30 | $6,754,688 | 50,135 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,848,972 | 49,250 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $8,203,808 | 50,763 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $6,738,684 | 50,210 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,856,035 | 51,293 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $8,073,078 | 49,800 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $6,283,237 | 46,405 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $4,614,678 | 42,780 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $4,737,525 | 42,059 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $4,326,094 | 39,975 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $3,996,587 | 37,299 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $3,159,984 | 36,077 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,669,182 | 37,372 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $2,831,601 | 37,165 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||